PRVA vs. LFST, USPH, PHR, ALHC, CYRX, PNTG, INNV, BEAM, ASTH, and NTLA
Should you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include LifeStance Health Group (LFST), U.S. Physical Therapy (USPH), Phreesia (PHR), Alignment Healthcare (ALHC), Cryoport (CYRX), The Pennant Group (PNTG), InnovAge (INNV), Beam Therapeutics (BEAM), Astrana Health (ASTH), and Intellia Therapeutics (NTLA).
Privia Health Group (NASDAQ:PRVA) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, risk, institutional ownership, dividends, analyst recommendations, valuation, media sentiment, profitability and earnings.
Privia Health Group has higher revenue and earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
94.5% of Privia Health Group shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 14.2% of Privia Health Group shares are held by company insiders. Comparatively, 8.5% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Privia Health Group currently has a consensus target price of $28.18, indicating a potential upside of 60.40%. LifeStance Health Group has a consensus target price of $8.60, indicating a potential upside of 51.14%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts plainly believe Privia Health Group is more favorable than LifeStance Health Group.
Privia Health Group has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500.
In the previous week, LifeStance Health Group had 4 more articles in the media than Privia Health Group. MarketBeat recorded 5 mentions for LifeStance Health Group and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.75 beat LifeStance Health Group's score of 0.67 indicating that Privia Health Group is being referred to more favorably in the media.
Privia Health Group received 42 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 71.83% of users gave Privia Health Group an outperform vote while only 24.32% of users gave LifeStance Health Group an outperform vote.
Privia Health Group has a net margin of 1.39% compared to LifeStance Health Group's net margin of -17.64%. Privia Health Group's return on equity of 3.97% beat LifeStance Health Group's return on equity.
Summary
Privia Health Group beats LifeStance Health Group on 15 of the 18 factors compared between the two stocks.
Get Privia Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Privia Health Group Competitors List
Related Companies and Tools
